- Filed
- May 7, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2026 · May 1, 2026 | 55.06M sh |
| Shares Diluted | Q2 2026 · Mar 31, 2026 | 55.73M sh |
| Shares Diluted | Q2 2026 · Mar 31, 2026 | 55.74M sh |
| Shares Diluted | Q2 2026 · Mar 31, 2025 | 55.44M sh |
| Shares Diluted | Q2 2026 · Mar 31, 2025 | 55.42M sh |
| Capex | Q2 2026 · Mar 31, 2026 | $52.66M |
| Capex | Q2 2026 · Mar 31, 2025 | $14.29M |
| Operating Cash Flow | Q2 2026 · Mar 31, 2026 | $7.07M |
| Operating Cash Flow | Q2 2026 · Mar 31, 2025 | $22.17M |
| Long Term Debt | Q2 2026 · Mar 31, 2026 | $127.78M |
| Long Term Debt | Q2 2026 · Sep 30, 2025 | $84.23M |
| Short Term Debt | Q2 2026 · Mar 31, 2026 | $2.95M |
| Short Term Debt | Q2 2026 · Sep 30, 2025 | $2.87M |
| Short Term Investments | Q2 2026 · Mar 31, 2026 | $74.75M |
| Short Term Investments | Q2 2026 · Sep 30, 2025 | $41.78M |
| Cash And Equivalents | Q2 2026 · Mar 31, 2026 | $87.23M |
| Cash And Equivalents | Q2 2026 · Sep 30, 2025 | $127.36M |
| Cash And Equivalents | Q2 2026 · Mar 31, 2025 | $96M |
| Cash And Equivalents | Q2 2026 · Sep 30, 2024 | $161.9M |
| Stockholders Equity | Q2 2026 · Mar 31, 2026 | $339.91M |
| Stockholders Equity | Q2 2026 · Dec 31, 2025 | $335.91M |
| Stockholders Equity | Q2 2026 · Sep 30, 2025 | $328.11M |
| Stockholders Equity | Q2 2026 · Mar 31, 2025 | $293.91M |
| Stockholders Equity | Q2 2026 · Dec 31, 2024 | $279.98M |
| Stockholders Equity | Q2 2026 · Sep 30, 2024 | $260.23M |
| Current Liabilities | Q2 2026 · Mar 31, 2026 | $207.93M |
| Current Liabilities | Q2 2026 · Sep 30, 2025 | $229.67M |
| Total Liabilities | Q2 2026 · Mar 31, 2026 | $512.28M |
| Total Liabilities | Q2 2026 · Sep 30, 2025 | $498.03M |
| Current Assets | Q2 2026 · Mar 31, 2026 | $243.79M |
| Current Assets | Q2 2026 · Sep 30, 2025 | $246.63M |
| Total Assets | Q2 2026 · Mar 31, 2026 | $852.19M |
| Total Assets | Q2 2026 · Sep 30, 2025 | $826.14M |
| Eps Diluted | Q2 2026 · Mar 31, 2026 | $0.01 |
| Eps Diluted | Q2 2026 · Mar 31, 2026 | $0.24 |
| Eps Diluted | Q2 2026 · Mar 31, 2025 | $0.21 |
| Eps Diluted | Q2 2026 · Mar 31, 2025 | $0.61 |
| Eps Basic | Q2 2026 · Mar 31, 2026 | $0.01 |
| Eps Basic | Q2 2026 · Mar 31, 2026 | $0.24 |
| Eps Basic | Q2 2026 · Mar 31, 2025 | $0.21 |
| Eps Basic | Q2 2026 · Mar 31, 2025 | $0.62 |
| Sga Expense | Q2 2026 · Mar 31, 2026 | $103.63M |
| Sga Expense | Q2 2026 · Mar 31, 2026 | $198.34M |
| Sga Expense | Q2 2026 · Mar 31, 2025 | $88.11M |
| Sga Expense | Q2 2026 · Mar 31, 2025 | $161.92M |
| Net Income | Q2 2026 · Mar 31, 2026 | $433K |
| Net Income | Q2 2026 · Mar 31, 2026 | $13.26M |
| Net Income | Q2 2026 · Dec 31, 2025 | $12.83M |
| Net Income | Q2 2026 · Mar 31, 2025 | $11.45M |
| Net Income | Q2 2026 · Mar 31, 2025 | $33.6M |
| Net Income | Q2 2026 · Dec 31, 2024 | $22.15M |
| Operating Income | Q2 2026 · Mar 31, 2026 | $339K |
| Operating Income | Q2 2026 · Mar 31, 2026 | $16.03M |
| Operating Income | Q2 2026 · Mar 31, 2025 | $16.85M |
| Operating Income | Q2 2026 · Mar 31, 2025 | $44.33M |
| Revenue | Q2 2026 · Mar 31, 2026 | $221.4M |
| Revenue | Q2 2026 · Mar 31, 2026 | $442.25M |
| Revenue | Q2 2026 · Mar 31, 2025 | $207.45M |
| Revenue | Q2 2026 · Mar 31, 2025 | $408.88M |